Related Experiment Video
Updated: Jul 14, 2026

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
Tobacco smoking and non-communicable disease comorbidity interactively attenuate PASI75 response in psoriasis: a
Jinrong Lu1,2, Yue Jiang3, Ruiqi Cai2
1Clinical Research & Innovation Transformation Center, Shanghai Skin Diseases Hospital, Medical School, Tongji University, Shanghai, China.
Introduction:
Tobacco smoking and non-communicable disease (NCD) comorbidities are positively associated with psoriasis severity, but their combined association with treatment response remains unclear. This study evaluated their interactive associations with PASI75 achievement.
Materials And Methods:
We prospectively recruited 551 psoriasis patients from Shanghai Skin Disease Hospital (2022-2024). Treatment efficacy was evaluated from baseline to Week 48. Logistic regression assessed associations of smoking and NCD comorbidities with PASI75, and additive interaction was examined using the relative excess risk due to interaction (RERI).
Results:
Tobacco smoking and NCD comorbidities were present in 51.2% and 42.6% of patients, respectively. Compared with those with both risk factors, patients with neither had higher PASI75 achievement at Weeks 8, 12, 24, and 48. At Week 48, PASI75 rates were 76.9% versus 55.8%, a 21.1% absolute difference. RERI indicated synergistic associations with PASI75 achievement at Week 12 (RERI = 0.71, 95% CI 0.05-2.38) and Week 24 (RERI = 0.80, 95% CI 0.11-2.39).
Conclusion:
Smoking and NCD comorbidities were jointly associated with poorer PASI75 achievement, while their concurrent absence was associated with added therapeutic benefit. These findings support integrating smoking cessation and NCD management into routine psoriasis care.
Trial Registration:
Chinese Clinical Trial Registry, ChiCTR2200066894.
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
